TAVR for severe aortic stenosis and papillary fibroelastoma in a high-risk setting.

Br J Cardiol

Cardiac Surgeon, and Division Head, Division of Cardiac Surgery St. Michael's Hospital and Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, M5B 1W8, Canada.

Published: April 2021

Papillary fibroelastomas (PFE) are rare benign cardiac tumours mainly originating on aortic and mitral valvular surfaces. Management is individualised, but most recommend surgical excision due to thromboembolic risk. We report a 75-year-old man with symptomatic severe aortic stenosis compounded by PFE. Redo sternotomy aortic valve replacement was deferred in favour of the trans-apical (TAVR) approach. This report highlights, for the first time, the application of TAVR as a strategy for aortic valve stenosis and PFE to mitigate risk posed by injury to patent internal mammary arterial graft in close proximity to the manubrium, and complications due to the patient's multiple comorbidities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822510PMC
http://dx.doi.org/10.5837/bjc.2021.023DOI Listing

Publication Analysis

Top Keywords

severe aortic
8
aortic stenosis
8
aortic valve
8
aortic
5
tavr severe
4
stenosis papillary
4
papillary fibroelastoma
4
fibroelastoma high-risk
4
high-risk setting
4
setting papillary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!